The diagnosis of Stage 0 primarily involves histological examination of tissue samples obtained through biopsies. Pathologists look for specific cellular abnormalities under the microscope. Advanced techniques such as immunohistochemistry and molecular testing may also be used to identify markers that indicate a higher risk of progression to invasive cancer.
